[Protective effects of d-chlorpheniramine maleate pre-treatment against acute side effects of Irinotecan(CPT- 11)].

Author: HashimotoMirai, HiraikeMikako, HondaShinobu, MisumiNobuhiro, NabeshimaAya, NawataFusako, TakaseIzumi, TanigawaKayoko

Paper Details 
Original Abstract of the Article :
It is wellknown that cholinomimetic side effects, such as sedation, abdominal pain, nasal flow and watery eyes, may develop in patients in the early stage of Irinotecan (CPT-11) administration; however, there have been no investigations concerning methods for preventing the development of these side...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/21772100

データ提供:米国国立医学図書館(NLM)

Irinotecan and d-Chlorpheniramine Maleate: A Protective Partnership

Irinotecan, a chemotherapy drug used to treat various cancers, can cause unpleasant side effects such as abdominal pain, nausea, and diarrhea. This research explores the potential of pre-treating patients with d-chlorpheniramine maleate (d-CM), an antihistamine, to prevent these side effects. It's like adding a shield of protection against the harsh effects of chemotherapy.

A Shield Against Chemotherapy Side Effects

The study found that pre-treating patients with d-CM significantly reduced the incidence of side effects associated with irinotecan. It's like building a wall of defense to protect against the enemy's attacks. The authors believe that d-CM may help to block the release of chemicals that cause these side effects, effectively shielding patients from their unwanted effects. It's like having a magic potion that neutralizes the harmful chemicals, allowing the patient to experience the benefits of chemotherapy without the burden of its side effects.

A New Approach to Cancer Treatment

This research offers a promising new approach to managing the side effects of chemotherapy. It's like finding a hidden spring of relief in the harsh desert of cancer treatment. The use of d-CM as a pre-treatment could significantly improve the quality of life for patients undergoing chemotherapy, allowing them to better tolerate the treatment and focus on recovery. This study is a testament to the ongoing search for ways to improve cancer treatment, making it more effective and tolerable for patients.

Dr.Camel's Conclusion

This research highlights the potential benefits of d-CM as a pre-treatment for irinotecan-induced side effects. It's like a protective oasis in the desert of chemotherapy, providing a shield against the harsh effects of treatment. This study is a testament to the ongoing efforts to improve cancer treatment, making it more tolerable and effective for patients.

Date :
  1. Date Completed 2011-08-05
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

21772100

DOI: Digital Object Identifier

21772100

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.